AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimegril M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Pharmacon Lifesciences Pvt. Ltd.

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimegril M 2mg/500mg Tablet ER

Diabex Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use, even with controlled blood sugar, is crucial. Discontinuing treatment without medical supervision could lead to elevated blood glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are paramount. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimegril M 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimegril M 2mg/500mg Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimegril M 2mg/500mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Glimegril M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimegril M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimegril M 2mg/500mg Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medication with a meal.

How Glimegril M 2mg/500mg Tablet ER works:

Glimegril M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glimegril M 2mg/500mg ER tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimepiride/Metformin 2mg/500mg tablets (Glimegril M) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimegril M tablets (2mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimegril M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimegril M 2mg/500mg Extended-Release tablets. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimegril M 2mg/500mg Extended-Release tablets cautiously, as dose modification may be necessary. Individuals with severe liver disease should avoid this medication. For those with mild to moderate liver disease, a low starting dose is typically recommended. Physician consultation is advised.

What if you forget to take Glimegril M 2mg/500mg Tablet ER :

Should you forget a Glimegril M 2mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimegril M 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimegril M 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimegril M 2mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Glimegril M and seek immediate medical attention.
Glimegril M 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimepiride/metformin (Glimegril M 2mg/500mg ER) may cause common side effects such as low blood sugar, taste changes, nausea, stomach upset, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimepiride/Metformin (Glimegril M 2mg/500mg ER) can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimepiride/Metformin (Glimegril M 2mg/500mg ER) can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimepiride/Metformin ER tablets (2mg/500mg) with alcohol is unsafe. Alcohol can further reduce blood sugar, risking hypoglycemia, and may heighten the risk of lactic acidosis.
Glimegril M 2mg/500mg Tab...
146
MRP 178
17% off